Yang, J., Li, Z., Deng, X., Li, M., Li, B., Thuku, R. C., . . . Fang, M. (2024). Kallikrein inhibitor derived from immunoglobulin heavy chain junction region possesses anti-thromboinflammation potential. Pharmacological research.
Chicago-Zitierstil (17. Ausg.)Yang, Juan, et al. Kallikrein Inhibitor Derived from Immunoglobulin Heavy Chain Junction Region Possesses Anti-thromboinflammation Potential. Pharmacological research, 2024.
MLA-Zitierstil (9. Ausg.)Yang, Juan, et al. Kallikrein Inhibitor Derived from Immunoglobulin Heavy Chain Junction Region Possesses Anti-thromboinflammation Potential. Pharmacological research, 2024.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.